The Decline of Clinical Trials in Central and Eastern Europe
Currently, 66% of clinical trials are conducted in North America, Western Europe and Australia.
Currently, 66% of clinical trials are conducted in North America, Western Europe and Australia. The U.S. hosts 49% of clinical trial sites and generates approximately 40% of clinical data. Other regions have arisen in recent years. The main reasons behind this globalization trend are the availability of highly skilled professionals in new research markets, lower costs, faster patient recruitment that allows for earlier drug application approvals and concentrations of huge populations for future drug sales.
Central and Eastern Europe participates in about 13% of clinical trials conducted in Europe and in about 5% of those conducted globally.
However, this number was as high as 7.5% in 2006. In relative terms, the decline here goes as far as 28% over the last six years. It has been observed in all countries of this region, especially Poland, Croatia and the Baltic states.
In this Applied Clinical Trials article, Thomas Novak, Maxim Belotserkovsky, and Ginny Payeur look at whether this surprising finding represents a fluctuation or a new trend.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
